A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2−) Advanced or Metastatic Breast Cancer
Article in Clinical Cancer Research (November 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (November 2023)
Article in Cancers (August 2023)
Article in Molecular Biomedicine (December 2022)